S100A8 and glioblastoma: The expression of S100A8 was remarkedly inhibited in GSC 20 and 267 with CCN1 silencing, while increased in GSC 8–11 after CCN1 overexpression with the same trend in GBM cell lines (Figure 4E,F and Supplementary Fig. S6A‐B).